Addex Therapeutics Ltd / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) N/A N/A N/A N/A N/A
    (estimated) N/A N/A N/A N/A N/A
    (estimated) N/A N/A N/A N/A N/A
    €437.81K -74.9% €7.64M -166.8% 1,746.0% +24 pp -€5.82M -32.7% -1,329.4% -8.3 pp
    €1.75M +13.4% -€11.44M -49.3% -654.5% +8.1 pp -€8.65M -51.4% -495.1% +6.6 pp
    €1.54M -51.2% -€22.54M +35.5% -1,462.6% -9.4 pp -€17.81M +12.0% -1,155.5% -6.5 pp
    €3.16M -19.3% -€16.63M +19.4% -526.4% -1.7 pp -€15.90M +21.1% -503.2% -1.7 pp
    €3.91M +30.8% -€13.93M -13.0% -355.9% +1.8 pp -€13.13M +28.2% -335.5% +0.067 pp
    €2.99M -54.3% -€16.01M +798.6% -535.0% -5.1 pp -€10.24M -636.9% -342.2% -3.7 pp
    €6.55M +1,109.0% -€1.78M -49.9% -27.2% +6.3 pp €1.91M -182.5% 29.1% +4.6 pp
    €541.60K +2,784.7% -€3.55M +4.2% -656.2% +180 pp -€2.31M -20.5% -426.9% +150 pp
    €18.77K -57.0% -€3.41M -25.1% -18,174.1% -77 pp -€2.91M +2.1% -15,483.7% -90 pp
    €43.66K -52.8% -€4.55M +136.9% -10,432.0% -84 pp -€2.85M +46.1% -6,522.0% -44 pp
    €92.53K -6.9% -€1.92M -87.7% -2,078.2% +140 pp -€1.95M -88.6% -2,107.2% +150 pp
    €99.41K -24.2% -€15.67M -45.7% -15,760.5% +62 pp -€17.09M -45.8% -17,193.1% +69 pp
    €131.19K -95.7% -€28.83M -14.5% -21,976.8% -210 pp -€31.55M +10.5% -24,050.1% -230 pp
    €3.06M +42.9% -€33.74M -7.4% -1,102.9% +6.0 pp -€28.54M -14.7% -933.1% +6.3 pp
    €2.14M -51.7% -€36.45M -21.2% -1,703.3% -6.6 pp -€33.46M -12.2% -1,563.7% -7.0 pp
    €4.43M -84.7% -€46.25M +93.5% -1,043.6% -9.6 pp -€38.10M +188.7% -859.6% -8.1 pp
    €29.04M +5,405.3% -€23.91M -37.1% -82.3% +71 pp -€13.20M -59.8% -45.4% +62 pp
    €527.55K -89.7% -€38.01M +70.8% -7,205.5% -68 pp -€32.80M +57.7% -6,217.6% -58 pp
    €5.13M -€22.26M -433.5% -€20.80M -405.2%

    Notifications